Literature DB >> 8111379

Mutations in the PAX6 gene in patients with hereditary aniridia.

A Davis1, J K Cowell.   

Abstract

The 14 exons of the PAX6 gene have been analysed exon-by-exon using SSCP in 6 aniridia families. In each family band shifts were observed on the SSCP gels for only one exon and direct PCR-sequencing revealed mutations in each case. Two mutations involved C-->T transitions in CGAarg codons in exons 9 and 11. Another C-->T transition converted a CAG-glutamine to a TAG-stop in exon 7. Small insertions created frameshifts which produced downstream stop codons in another two patients and an A-->T mutation disrupted the splice donor site of exon 5 in the remaining family. Thus, complete inactivation of the PAX6 gene is predicted in all cases. Analysis of other affected members of the families showed that, in each case, all affected individuals carried the same family-specific mutation. One polymorphism was found in exon 7. This data strongly supports the candidature of PAX6 as the gene responsible for hereditary aniridia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8111379     DOI: 10.1093/hmg/2.12.2093

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

1.  Peters' anomaly.

Authors:  T Jordan
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

Review 2.  The genetics of complex ophthalmic disorders.

Authors:  K Evans; A C Bird
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

3.  DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5).

Authors:  T Czerny; M Busslinger
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

4.  Novel presentation of Omenn syndrome in association with aniridia.

Authors:  William J Sheehan; Ottavia M Delmonte; David T Miller; Amy E Roberts; Francisco A Bonilla; Massimo Morra; Silvia Giliani; Sung-Yun Pai; Luigi D Notarangelo; Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

Review 5.  Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases.

Authors:  Ales Cvekl; Ernst R Tamm
Journal:  Bioessays       Date:  2004-04       Impact factor: 4.345

6.  Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene.

Authors:  M Drechsler; E J Meijers-Heijboer; S Schneider; B Schurich; C Grond-Ginsbach; G Tariverdian; G Kantner; A Blankenagel; D Kaps; T Schroeder-Kurth
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

7.  Functional properties of natural human PAX6 and PAX6(5a) mutants.

Authors:  Bharesh K Chauhan; Ying Yang; Kveta Cveklová; Ales Cvekl
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

8.  Mutation of the PAX6 gene in patients with autosomal dominant keratitis.

Authors:  F Mirzayans; W G Pearce; I M MacDonald; M A Walter
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

9.  Eye anomalies and neurological manifestations in patients with PAX6 mutations.

Authors:  Yin-Hsuan Chien; Hsiang-Po Huang; Wuh-Liang Hwu; Yin-Hsiu Chien; Tseng-Ching Chang; Ni-Chung Lee
Journal:  Mol Vis       Date:  2009-10-22       Impact factor: 2.367

10.  PAX6 analysis of two sporadic patients from southern China with classic aniridia.

Authors:  Ying Lin; Xialin Liu; Shanshan Yu; Lixia Luo; Xuanwei Liang; Zhonghao Wang; Chuan Chen; Yi Zhu; Shaobi Ye; Hong Yan; Yizhi Liu
Journal:  Mol Vis       Date:  2012-08-07       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.